Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 63,461 4.990% | 13,461 (+26.92%) | Filing History |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 50,000 8.930% | 36,409 (+267.90%) | Filing History |
| 2025-02-14 5:51 pm Purchase | 2024-12-31 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 13,591 9.990% | 1,551 (+12.88%) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 12,040 9.990% | 12,040 (New Position) | Filing History |
| 2024-02-14 3:43 pm Purchase | 2023-12-31 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 8,843 9.990% | 8,843 (New Position) | Filing History |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | The Vanguard Group | 1,579 0.950% | 422 (+36.49%) | Filing History |
| 2021-01-20 11:14 am Sale | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | Empery Asset Management, LP | 1,329 4.570% | -338 (-20.27%) | Filing History |
| 2021-01-04 2:02 pm Sale | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | SABBY MANAGEMENT LLC | 1,385 11.000% | -281 (-16.88%) | Filing History |